Paclitaxel
5 NDCs across 2 manufacturers|5 Generic,0 Brand
Paclitaxel is used to treat breast neoplasms, non-small-cell lung carcinoma, ovarian neoplasms and kaposi sarcoma, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 29, 1992, and the first generic was approved Jan 25, 2002. FDA's Orange Book lists 7 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $204K on Paclitaxel across 2,204 claims for 677 beneficiaries.
Paclitaxel is available as 5 NDCs from 2 manufacturers (5 generic, 0 brand), with NADAC prices from $1.77 to $2.13 per ML — a 20% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
2
competing in market
Price Spread
$1.77 – $2.13
per ML
7d Activity
avg +0.0% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Hospira Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Microtubule Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing PACLITAXEL
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PACLITAXEL 30 MG/5 ML VIAL | $2.1290 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL | $1.8891 per ML | — |
PACLITAXEL 100 MG/16.7 ML VIAL | $1.8891 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL | $1.7700 per ML | — |
PACLITAXEL 300 MG/50 ML VIAL | $1.7700 per ML | — |
Frequently Asked Questions
What is Paclitaxel used to treat?
Paclitaxel is used to treat breast neoplasms, non-small-cell lung carcinoma, ovarian neoplasms and kaposi sarcoma, per the National Library of Medicine's MED-RT classification.
When did Paclitaxel become available as a generic?
FDA approved the first generic Paclitaxel (ANDA) on Jan 25, 2002. The Orange Book currently lists 7 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Paclitaxel?
In 2024, Medicare Part D spent $204K on Paclitaxel across 2,204 claims for 677 beneficiaries.
How many Paclitaxel products are on the market?
The Paclitaxel drug market contains 5 NDCs from 2 manufacturers — 5 generic and 0 brand products.
What is the price range for Paclitaxel?
NADAC reference prices for Paclitaxel range from $1.7700 to $2.1290 per ML — a 20% difference between cheapest and most expensive.
Which manufacturers make Paclitaxel?
2 manufacturers list Paclitaxel in NADAC. Ranked by number of NDCs, the largest are Hospira Inc. (3), Fresenius Kabi USA, LLC (2).